(Q45941403)

18 December 2017

title

Gem-diamine 1-N-iminosugars as versatile glycomimetics: synthesis, biological activity and therapeutic potential. (English)

1 reference

18 December 2017

author name string

Yoshio Nishimura

series ordinal

1

1 reference

18 December 2017

publication date

3 July 2009

1 reference

18 December 2017

The Journal of Antibiotics

published in

1 reference

18 December 2017

volume

62

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

407-423

1 reference

18 December 2017

Naturally occurring iminosugars and related compounds: structure, distribution, and biological activity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

General methods for iminosugar synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Nomenclature of carbohydrates (IUPAC Recommendations 1996)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Inhibitors of Carbohydrate-Processing Enzymes: Design and Synthesis of Sugar-Shaped Heterocycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Flexible synthesis and biological activity of uronic acid-type gem-diamine 1-N-iminosugars: a new family of glycosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

gem-diamine 1-N-iminosugars of L-fucose-type, the extremely potent L-fucosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

A facile synthesis of D-glucose-type gem-diamine 1-N-iminosugars: a new family of glucosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Human heparanase. Purification, characterization, cloning, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to L-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Molecular diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Emergence of nuclear heparanase induces differentiation of human mammary cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Involvement of heparanase in migration of microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Heparan sulfate: decoding a dynamic multifunctional cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

The role of proteoglycans in cell adhesion, migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Collagenolytic mechanisms in tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

The molecular basis of lysosomal storage diseases and their treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

New prospects for the treatment of lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Treatment of lysosomal storage disorders: cell therapy and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

Purification and characterization of a sialidase inhibitor, siastatin, produced by Streptomyces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Totally synthetic analogues of siastatin B. III. Trifluoroacetamide analogues having inhibitory activity for tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Synthesis and activity of 1-N-iminosugar inhibitors, siastatin B analogues for alpha-N-acetylgalactosaminidase and beta-N-acetylglucosaminidase

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Siastatin B, a potent neuraminidase inhibitor: the total synthesis and absolute configuration

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Totally synthetic analogues of siastatin B. I. Optically active 2-acetamidopiperidine derivatives

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Totally synthetic analogues of siastatin B. II. Optically active piperidine derivatives having trifluoroacetamide and hydroxyacetamide groups at C-2

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

A practical synthesis from siastatin B of (3S,4S,5R,6R)- 4,5-dihydroxy-6-(trifluoroacetamido)piperidine-3-carboxylic acid having antimetastatic activity in mice

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Synthesis and antimetastatic activity of 6-trichloroacetamido and 6-guanidino analogues of siastatin B

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Synthesis and antimetastatic activity of L-iduronic acid-type 1-N-iminosugars

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

A facile synthesis of D-galactose-type gem-diamine 1-N-iminosugar: a new family of galactosidase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Glycosidase inhibitors of gem-diamine 1-N-iminosugars. structures in media of enzyme assays

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Cysteine proteinases and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Effect on spontaneous metastasis of mouse Lewis lung carcinoma by a trifluoroacetamide analogue of siastatin B

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

The molecular biology of influenza virus pathogenicity

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Inhibition of Glycosphingolipid Biosynthesis: Application to Lysosomal Storage Disorders

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.53

7 January 2021

Identifiers

DOI

10.1038/JA.2009.53

1 reference

18 December 2017

Dimensions Publication ID

1001214834

0 references

1 reference

18 December 2017